ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: S. Janes (London, United Kingdom), G. Stella (Pavia, Italy)

LSC - 2017 - Reprogramming Of Tumor Associated Macrophages By Modulating Wnt/ß-catenin Signalling In Lung Cancer. P. Sarode (Bad Nauheim, Germany)
Interplaying between Gamma-H2AX and autophagy in A549 cells treated with cisplatin and etoposide J. Shin (Seoul, Republic of Korea)
LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma G. Giotopoulou (Patra, Greece)
Fusion transcripts in lung cancer F. Baty (St. Gallen, Switzerland)
Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response. I. Kwiecien (Warszawa, Poland)
The influence of conventional and targeted chemotherapy on the expression of stem cell markers in lung cancer cell lines A. Frille (Leipzig, Germany)
High CO2 tumor microenvironment confers chemoresistance in lung cancer cells. R. Kikuchi (Tokyo, Japan)
Comparative metabolomic study of lung cancer based on serum, urine and bronchoalveolar lavage fluid. B. Urizar Catalan (Huelva, Spain)